Literature DB >> 30199918

Sarcopenia - Endocrinological and Neurological Aspects.

Michaela Katja Stangl1, Wolfgang Böcker2, Vladimir Chubanov3, Uta Ferrari1, Michael Fischereder4, Thomas Gudermann3, Eric Hesse5, Peter Meinke6, Martin Reincke1, Nicole Reisch1, Maximilian M Saller2, Jochen Seissler1, Ralf Schmidmaier1, Benedikt Schoser6, Cornelia Then1, Barbara Thorand7, Michael Drey1.   

Abstract

Sarcopenia in geriatric patients is often associated with or even caused by changes of the endocrine and nervous system. The multifactorial pathogenesis of sarcopenia and additional multimorbidity in geriatric patients makes it difficult to study distinct pathogenic pathways leading to sarcopenia. Patients suffering from diabetes, Cushing's syndrome, chronic kidney disease, Klinefelter's syndrome or motor neuron diseases, such as amyotrophic lateral sclerosis for example are known to have impaired muscle property and reduced physical performance. These patients are typically younger and suffer from conditions caused by a known molecular disease mechanism and a peculiar sarcopenic phenotype. Therefore, these sequelae can serve as prototypic disease models to study isolated endocrinological and neurodegenerative causes for sarcopenia. This review focuses on diseases whose etiopathogenesis of muscle impairment is known. The idea is to use these diseases as proof of principles to develop a classification algorithm of sarcopenia in the elderly to make a more mechanism-oriented therapy be possible. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30199918     DOI: 10.1055/a-0672-1007

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  9 in total

Review 1.  [Osteosarcopenia].

Authors:  M Drey; R Schmidmaier
Journal:  Internist (Berl)       Date:  2021-04-16       Impact factor: 0.743

2.  Follistatin-induced muscle hypertrophy in aged mice improves neuromuscular junction innervation and function.

Authors:  Chitra C Iyer; Deepti Chugh; Prameela J Bobbili; Anton J Blatnik Iii; Alexander E Crum; Allen F Yi; Brian K Kaspar; Kathrin C Meyer; Arthur H M Burghes; W David Arnold
Journal:  Neurobiol Aging       Date:  2021-03-12       Impact factor: 5.133

3.  Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing's Disease.

Authors:  Valentina Guarnotta; Antonio Prinzi; Maria Pitrone; Giuseppe Pizzolanti; Carla Giordano
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-11       Impact factor: 3.168

4.  [Diagnostic and therapeutic approach to sarcopenia].

Authors:  Anna Schaupp; Sebastian Martini; Ralf Schmidmaier; Michael Drey
Journal:  Z Gerontol Geriatr       Date:  2021-09-20       Impact factor: 1.281

Review 5.  Anabolic-Androgenic Steroids and Exercise Training: Breaking the Myths and Dealing With Better Outcome in Sarcopenia.

Authors:  Hugo Falqueto; Marcelo Rodrigues Dos Santos; Leandro H Manfredi
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

6.  Associations of intermuscular adipose tissue and total muscle wasting score in PG-SGA with low muscle radiodensity and mass in nonmetastatic colorectal cancer: A two-center cohort study.

Authors:  Yang Wang; Yuliuming Wang; Guodong Li; Hao Zhang; Hang Yu; Jun Xiang; Zitong Wang; Xia Jiang; Guoqing Yan; Yunxiao Liu; Chunlin Wang; Huan Xiong; Guiyu Wang; Hanping Shi; Ming Liu
Journal:  Front Nutr       Date:  2022-08-25

7.  Circulating C-Terminal Agrin Fragment: A Potential Marker for Sarcopenia Among Type 2 Diabetes.

Authors:  Pranathi Racha; Sumithra Selvam; Beena Bose; Ganapathi Bantwal; Sucharita Sambashivaiah
Journal:  Indian J Endocrinol Metab       Date:  2022-09-20

Review 8.  Growth Hormone Secretagogues and the Regulation of Calcium Signaling in Muscle.

Authors:  Elena Bresciani; Laura Rizzi; Silvia Coco; Laura Molteni; Ramona Meanti; Vittorio Locatelli; Antonio Torsello
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

9.  Serum uromodulin is inversely associated with the metabolic syndrome in the KORA F4 study.

Authors:  Cornelia Then; Holger Then; Andreas Lechner; Cornelia Huth; Christa Meisinger; Margit Heier; Annette Peters; Wolfgang Koenig; Wolfgang Rathmann; Christian Herder; Michael Roden; Jürgen Scherberich; Jochen Seissler
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.